top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Les substances d’origine végétale en Côte d’Ivoire : Potentiel et développement durable = : Plant-based substances in Côte d’Ivoire : Potential and Sustainable Development
Les substances d’origine végétale en Côte d’Ivoire : Potentiel et développement durable = : Plant-based substances in Côte d’Ivoire : Potential and Sustainable Development
Pubbl/distr/stampa Marseille, France : , : IRD Éditions, , 2022
Descrizione fisica 1 online resource (206 pages) : illustrations ; ; digital file (PDF)
Collana Collection Expertise collective
Soggetto topico Ethnobotany - Côte d'Ivoire
Traditional medicine - Côte d'Ivoire
Sustainable development
Ethnobotany
Traditional medicine
Soggetto non controllato plant biodiversity
economic development
public health
pharmacopeia
cultural heritage
environmental and health economics
ISBN 2-7099-2917-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione fre
Altri titoli varianti Plant-based substances in Côte d’Ivoire. Potential and Sustainable Development
Record Nr. UNINA-9910765527803321
Marseille, France : , : IRD Éditions, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Looking Forward to the Future of Heparin: New Sources, Developments and Applications
Looking Forward to the Future of Heparin: New Sources, Developments and Applications
Autore Fareed Jawed
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2018
Descrizione fisica 1 electronic resource (282 p.)
Soggetto non controllato alginate
edema
Heparin Red
solid lipid nanoparticles
Fe3O4·DA-BSA/HA
dermatan sulfate
sulfated alginate
porcine heparin
theranostics
low-molecular-weight heparin
Arixtra®
biomaterials
hepcidin
ovarian cancer
iron oxide nanoparticles
heparin-induced thrombocytopenia
bone morphogenetic protein (BMP)
hyaluronic acid (HA)
crude heparin
platelets
resistance
sclerostin
LMWH
gremlin
low molecular weight heparin (LMWH)
low molecular weight glycosaminoglycans
human plasma
single crystal X-ray structure
iron homeostasis
noggin
super paramagnetic iron oxide nanoparticles (SPION)
manufacturing methods
paclitaxel (PTX)
brain injury
bovine heparin
inflammation
qNMR
antithrombin
reference standard
quantitative NMR
enoxaparin
danaparoid sodium
NMR
GDNF
orthogonal multi-analytical methods
ternary complex
heparan sulphate
serglycin
bovine serum albumin (BSA)
HSQC
recombinant expression
heparin
heparin oligosaccharides
functional assay
BMP antagonists
intestinal lymphatic absorption
size exclusion chromatography
heparin coating
diagnosis
bioreactor
anemia
proteoglycan
heparin process
PCA
chemometric
fluorescent probe
pharmacopeia
affinity chromatography
component quantitative analysis
Fondaparinux sodium
perylene diimide dyes
thrombin inhibition
extended physicochemical characterization
cisplatin
glycosaminoglycans
TGF-?
chondroitin sulfate
dalteparin
sequence and compositional investigations
molecular weight
magnetic resonance imaging (MRI)
industrial
LC-MS
iduronic acid conformation
heparan sulfate
growth and differentiation factor (GDF)
assay
subarachnoid hemorrhage
ISBN 3-03842-950-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Looking Forward to the Future of Heparin
Record Nr. UNINA-9910346841803321
Fareed Jawed  
MDPI - Multidisciplinary Digital Publishing Institute, 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui